RE: Moving North27 Oct 2021 20:15
hi earache, in fairness to CF, he never subscribed to the goldmans $1bn valuation. While he has always referred to it as the "golden lottery ticket" he was using a ball park figure of $300 to $500k.
Only my opinion but what happened with biondvax probably did us no favours on the potential sale of a phase 3 ready fluV product.
As to how it will eventually get to market, I guess it is a case of wait and see. If my memory serves me correctly, at the last Orph presentation CF alluded to some kind of update within a couple of weeks.
Maybe the guys at the event on 3rd November can ask the question.